EVG vs. APTA, FAB, OCTP, IXI, VAL, PYC, BSFA, NFX, ROQ, and GENF
Should you be buying Evgen Pharma stock or one of its competitors? The main competitors of Evgen Pharma include Aptamer Group (APTA), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), Physiomics (PYC), BSF Enterprise (BSFA), Nuformix (NFX), Roquefort Therapeutics (ROQ), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.
Evgen Pharma (LON:EVG) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk, earnings and community ranking.
Evgen Pharma's return on equity of -60.57% beat Aptamer Group's return on equity.
Evgen Pharma has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Aptamer Group has a beta of -0.42, indicating that its share price is 142% less volatile than the S&P 500.
27.8% of Evgen Pharma shares are owned by institutional investors. Comparatively, 1.5% of Aptamer Group shares are owned by institutional investors. 32.4% of Evgen Pharma shares are owned by insiders. Comparatively, 31.7% of Aptamer Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Evgen Pharma received 193 more outperform votes than Aptamer Group when rated by MarketBeat users.
Evgen Pharma has higher earnings, but lower revenue than Aptamer Group. Evgen Pharma is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Evgen Pharma's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score.
Summary
Evgen Pharma beats Aptamer Group on 7 of the 10 factors compared between the two stocks.
Get Evgen Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evgen Pharma Competitors List
Related Companies and Tools
